Alice Yam
Vice President, Early Development & Strategic Program Management Sutro Biopharma
Seminars
Tuesday 13th October 2026
Presentation Preview: Driving Clinical Success with STRO-006: Breaking Down Insights from PDX Response & Translational Biomarkers
- Outlining design and development of STRO-006, an integrin beta-6 targeted DAR8 Topo1 ADC
- Evaluating STRO-006 in a PDX clinical trial to identify biomarkers correlating with response
- Undergoing translational workstreams to enable successful clinical development
